Waldbrunn, Germany

Peter Schmid

This inventor holds 1 USPTO granted patent. Top assignee: Akzo Nobel N.v.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Schmid. Retrieved from https://idiyas.com/inventor/peter-schmid-zw3rk0cq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter Schmid

Introduction

Peter Schmid is a notable inventor based in Waldbrunn, Germany. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approach to drug delivery systems. His work focuses on enhancing the effectiveness of medications through advanced formulations.

Latest Patents

Peter Schmid holds a patent for a prolonged release pharmaceutical composition. This novel pharmaceutical composition involves a cephalosporin in a prolonged release vehicle, which includes an oil and aluminium distearate. This formulation is designed to provide a prolonged duration of effective blood-plasma concentration of the cephalosporin after injection to animals. His patent represents a significant advancement in pharmaceutical technology.

Career Highlights

Throughout his career, Peter Schmid has been associated with Akzo Nobel N.V., a leading company in the field of coatings and specialty chemicals. His work at Akzo Nobel has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in pharmaceuticals.

Collaborations

Peter has worked alongside notable colleagues such as Carsten Schmidt and Alexander Boettner. Their combined expertise has fostered an environment of innovation and creativity, leading to the development of effective pharmaceutical solutions.

Conclusion

Peter Schmid's contributions to the pharmaceutical industry through his innovative patent demonstrate his commitment to improving drug delivery systems. His work continues to influence the field and pave the way for future advancements in medication efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…